Sanofi (SNY) Financial Statements
Sanofi (SNY) files with the U.S. Securities and Exchange Commission under CIK 0001121404. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Net Income
- 7.85 billion EUR
- Total Assets
- 126.81 billion EUR
- Net Cash from Operations
- 10.75 billion EUR
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Feb 17, 2026. Source: SEC filings (EDGAR XBRL). Amounts in EUR.
Open the full financial statements for SNY in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History